Movement cytometric immunophenotypic adjustments involving chronic clonal haematopoiesis throughout remission navicular bone marrows involving sufferers with NPM1-mutated serious myeloid leukaemia.
https://www.selleckchem.com/products/mivebresib-abbv-075.html